PA GOODDOCTOR (01833) Wins WISE2025 "King of Business" Award for Breakthrough in AI Application Scenarios

Stock News2025-12-01

On November 27, the WISE2025 "King of Business" conference was held in Beijing. PA GOODDOCTOR (01833) was honored with the "Breakthrough in AI Application Scenarios" award for its deep integration of artificial intelligence into healthcare services.

The WISE2025 "King of Business" event is a premier annual gathering focusing on trending sectors such as AI, globalization, and branding. The "Breakthrough in AI Application Scenarios" award recognizes companies that have successfully commercialized AI technologies across diverse fields, including large-scale models, AIGC, robotics, and autonomous driving.

PA GOODDOCTOR's win underscores its technological prowess and practical application capabilities, earning industry-wide recognition. Aligned with China's strategic goal of technological self-reliance, the company has actively advanced its "AI+" initiative, integrating AI with healthcare to enhance service quality and efficiency.

This year, PA GOODDOCTOR launched its "7+N+1" medical AI product ecosystem, creating a closed-loop system of data, models, and application scenarios to improve end-to-end healthcare services. Its flagship "AI Family Doctor" features a three-tier product matrix—AI doctors, AI assistants, and AI-MDT—operating under a strict "AI suggestion + physician oversight" safety protocol.

Currently, AI-assisted consultations achieve an accuracy rate of approximately 98%, while complex disease MDT treatment plans reach nearly 90% accuracy. AI-supported doctors can handle up to 4 million daily consultations.

Moving forward, PA GOODDOCTOR will continue to innovate and refine its AI-driven healthcare solutions, prioritizing user needs to deliver comprehensive, high-quality, and compassionate medical services across all scenarios.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment